Bigul

PANACEA BIOTEC LTD. - 531349 - Board Meeting Intimation for For Approving Standalone And Consolidated Audited Financial Results For Financial Year Ended March 31, 2023

PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve the Audited Financial Results for the Financial Year ended March 31, 2023. Further, with reference to our earlier announcement dated March 30, 2023 intimating the Closure of Trading Window pursuant to the Company''s Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the trading window of the Company shall remain closed for all Designated Persons of the Company till June 01, 2023 and the same will re-open from June 02, 2023.
15-05-2023
Bigul

PANACEA BIOTEC LTD. - 531349 - Details Of Shares Dematerialized During April, 2023 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018

This is with reference to CDSL's Operating Instructions for Issuers/RTAs, which states that the Issuer/RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed. Accordingly, we are enclosing herewith the data of shares dematerialized during the month of April, 2023 along with a copy of the certificate obtained from the Company's RTA viz. Skyline Financial Services Pvt. Ltd., regarding shares dematerialized as on April 30, 2023 .
05-05-2023
Bigul

PANACEA BIOTEC LTD. - 531349 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyPANACEA BIOTEC LTD. 2CIN NO.L33117PB1984PLC022350 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 15.24 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Vinod Goel Designation: Group CFO and Head Legal and Company Secretary EmailId: vinodgoel@panaceabiotec.com Name of the Chief Financial Officer: Devender Gupta Designation: Chief Financial Officer and Head Information Technology EmailId: devendergupta@panaceabiotec.com Date: 29/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
29-04-2023
Bigul

PANACEA BIOTEC LTD. - 531349 - Certificate Pursuant To Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended March 31, 2023

Pursuant to the provisions of Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the certified copy of certificate from M/s. R & D, Company Secretaries, for the financial year ended March 31, 2023, confirming that all the share certificates have been issued by the Company within the stipulated time from the date of lodgement for transfer, sub-division, consolidation, renewal, exchange or endorsement of calls/allotment monies, as the case may be.
11-04-2023
Bigul

PANACEA BIOTEC LTD. - 531349 - Details Of Shares Dematerialized During March, 2023

Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we are enclosing herewith the data of shares dematerialized during the month of March, 2023
07-04-2023
Bigul

PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

We are enclosing herewith a certificate dated April 03, 2023, issued by Skyline Financial Services Private Limited, Registrar and Transfer Agent of the Company, confirming compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2023.
07-04-2023
Bigul

PANACEA BIOTEC LTD. - 531349 - Compliance Certificate For The Financial Year Ended March 31, 2023

Pursuant to the provisions of Regulation 7(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are enclosing herewith the certificate duly signed by Skyline Financial Services Pvt. Ltd., Share Transfer Agent and Company Secretary of Panacea Biotec Ltd. for the financial year ended on March 31, 2023 in compliance of Regulation 7(2) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
07-04-2023
Bigul

PANACEA BIOTEC LTD. - 531349 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nirmala Jain
05-04-2023
Bigul

PANACEA BIOTEC LTD. - 531349 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Rajesh Jain
05-04-2023
Bigul

PANACEA BIOTEC LTD. - 531349 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nirmala Jain
31-03-2023
Next Page
Close

Let's Open Free Demat Account